Skip to content

Novo Nordisk Foundation

Regenerative Medicine Catalyst Grants

Up to DKK 5M (standard) / Up to DKK 10M (collaborative); total pool DKK 100M| Deadline: 1 September 2026 (58 days)|Up to 3 years

Two-phase process; Phase I concept note deadline not specified. Webinar on 4 August 2026. Grants awarded over 2026–2027.

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

Details

Funder Novo Nordisk Foundation
Budget Up to DKK 5M (standard) / Up to DKK 10M (collaborative); total pool DKK 100M
Deadline 1 September 2026
Duration Up to 3 years
Consortium No (optional for standard; required for collaborative projects — at least 1 international co-applicant from a different country)
Application 2-stage: Phase I concept note → Phase II full application with external peer review
Eligible countries DKSENOFIISGLFO

Eligibility & scope

Main applicant must be an established investigator at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands). Translational/applied focus on stem cell-based therapies across four themes: allogeneic cell therapy, analytical methods, biomaterials, and clinical development. Fundamental discovery, adult immune cell (CAR-T/NK), and gene therapy projects are out of scope. For-profit partners may collaborate but cannot receive direct funding.

View full call →

More from Novo Nordisk Foundation

Browse all open grants →

Browse Related

Could Regenerative Medicine Catalyst Grants be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →